Subscribe to our Newsletters !!

    Kumar Jeetendra

    Natco Pharma gets USFDA gesture for generic cancer trearment drug

    New Delhi, May 22 (PTI) Natco Pharma on Saturday said it has received approval from the US health regulator for generic Lenalidomide capsules indicated for treatment of adults with multiple myeloma, mantle cell lymphoma and myelodysplastic syndromes. The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new

    Sun Pharma reviews 50,868 bottles of diabetes drug in US

    New Delhi, May 21 (PTI) Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA). The US-based arm of the drug firm is recalling the affected lot of 500 mg tablets (in 500 count bottles) due to

    New chemical interaction utilizes photocatalytic layer to eliminate steroid hormones

    Micropollutants like steroid hormones contaminate drinking water worldwide and pose a substantial threat to human health and the environment even in smallest quantities. Until today, readily scalable water treatment technologies that remove them economically and sustainably have been lacking. It takes advantage of the mechanisms of photocatalysis and transforms the pollutants into possibly safe oxidation

    Bal Pharma dispatches antiviral drug Favipiravir at Rs 85/tablet

    Drug maker Bal Pharma on Monday said it has launched antiviral drug Favipiravir in the domestic market under the brand name BALflu for the treatment of COVID-19. The Bengaluru-based company said its formulation would be available in tablet form with 400 mg strength. Favipiravir is being used for patients with mild to moderate COVID-19 infection as it

    Mild cases of COVID-19 give enduring antibody, shows study

    Months after recovering from mild cases of COVID-19, people still possess immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all of the while. The

    Glenmark Pharma gets USFDA gesture for Icatibant Injection

    Drug major Glenmark Pharma on Monday said it has received final approval from the US health regulator for Icatibant Injection, indicated for the treatment of acute attacks of hereditary angioedema (HAE). Hereditary angioedema (HAE) is a disorder that results in recurrent attacks of severe swelling. The approved product is a generic version of Firazyr Injection

    Getting to grips with granulation: a new eBook from Freeman Technology

    An in-depth assessment of the application and value of powder flow testing in the optimisation of granulation processes. A new eBook from Freeman Technology, a Micromeritics company and global leader in powder characterisation, explores the application of powder flow measurements for monitoring and optimising granulation processes. Granulation is a vital unit operation for many industries,

    Rapid Removal of gDNA from RNA Samples

    Porvair Sciences has launched Chromatrap® gDNA Removal Columns that quickly remove unwanted genomic DNA (gDNA) from RNA samples. Removal of gDNA from RNA samples is of particular important to scientists undertaking RT-PCR, RNA-seq and microarray-based applications where the high purity and accurate measurement of RNA is vital. Employing a simple load and spin method the